Outlook Therapeutics, Inc. (OTLK): SCHEDULE 13D/A filed May 28, 2025

Form type

SCHEDULE 13D/A

Filing date

May 28, 2025

Accession number

0000947871-25-000572

Filer

Outlook Therapeutics, Inc. (CIK 1649989)